TABLE 1

Demographics and Clinical Characteristics

VariableShortened IV Therapy, N = 163Prolonged IV Therapy, N = 612P
Female sex, n (%)81 (50)289 (47).58a
Age, d, n (%) <.01b
 7–3013 (8)80 (13)
 31–90124 (76)475 (78)
 >9026 (16)57 (9)
Race and/or ethnicity, n (%).74a
 Non-Hispanic white62 (38)215 (35)
 Non-Hispanic African American59 (36)251 (41)
 Hispanic23 (14)81 (13)
 Other19 (12)65 (11)
Primary payer, n (%).08a
 Government111 (68)367 (60)
 Commercial insurance or self-pay41 (25)172 (28)
 Unknown11 (7)73 (12)
History of prematurity, n (%)1 (1)16 (3).12a
Complex chronic condition, n (%)19 (12)63 (10).62a
Concomitant urinary tract infection, n (%)23 (14)32 (5)<.01a
Case mix index, median (IQR)1.03 (0.99–1.11)1.04 (1.00–1.11).52c
Admission y, median (IQR)2007 (04–12)2009 (05–12)<.02c
  • a χ2 test.

  • b Mann–Whitney U test.

  • c t test.